1Matozaki T,Sakamoto C,Matsuda k,et al.Missense mutation and a deletion of the p53 gent in human gastric cancer[J].Biochem Biophys Res commun,1992,182(1):215-223.
3Ohashi M,Kanai F,Uen h,et al.Adenovirus mediated P53 turmor suppressor gene therapy for human gastric cancer cells in vitro and vivo[J].Gut,1999,44(3):366-371.
4Matozaki T,sakmoto C,Suzuki T,et al.p53 gene matations in human gastic Cancer:wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells[J].Cancer Res,1992,52(16);4335-4341.
6Kitadai Y,Yamazaki H,Yagui W,et al.GC factor represses transcription of several factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines[J].Cell Growth Differ,1993;4(4):291-296.
7Mizutani T,Onda M,Tokunage A,et al.Relationship of c-erbB-2 Protein expression and gene amplification to invasion and emtastasis in human gastric cancer[J].Cancer,1993,1003,72(7):2083-2088.
8Wels W,Moritz D,Schmidt M,et al.Biotechnological and gene therapeutic strategies in cancer treatment[J].Cancer,1995,159(1):73-80.
9Ogiso Y,Sakai N,watari H,et al.Suppression of various human tumor cell lines by a dominant negative H-ras mutant[J].Gene Ther,1994,1(6):403-407.
10Reed JC.Promise and problems of bcl-2 antisense therapy[J].J Natl Cancer Inst,1997,89(14):988-990.
6Stabile-Ianora A A,Pedote P,Scarda D A,et al. Preoperative spiral CT[J]. Radiol Med, 2003,106(5-6) :467-480.
7Gore RM. Upper gastrointestinal tract tumours diagnosis and staging strategies[J]. Cancer Img, 2005,5 (1) : 95 -- 98.
8Kobayashi O,Sugiyama Y, Cho H, et al. Clinical and pathological study of gastric cancer with ovarian inetastasis[J]. Int J Clin Oncol, 2003,8(2) :67-71.
9Minami M, Kaqauchi N, Itai Y, et al. Gastric tumor: radiologic path ologic correlation and accuracy of T staging with dynamical CT[J]. Radiology, 1997,18 5 : 173 -- 178.
